| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
60,035,000
|
53,872,000
|
39,717,000
|
54,392,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
60,035,000
|
53,872,000
|
39,717,000
|
54,392,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 40,141,000 | 36,660,000 | 34,084,000 | 37,802,000 | | | |
Operating Income or Loss
|
19,894,000
|
17,212,000
|
5,633,000
|
16,590,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes |
-
|
-
|
-
|
-
|
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 3,928,000 | 4,846,000 | 385,000 | 2,809,000 |
|
Minority Interest | (1,147,000) | (1,032,000) | (860,000) | (770,000) |
|
|
|
Net Income From Continuing Ops | 17,944,000 | 14,191,000 | 6,694,000 | 6,498,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
16,797,000
|
13,159,000
|
5,834,000
|
5,728,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|